viimane versioon :
29/10/2024
Antihüpertensiivne ravim   Hydralazine hydrochloride  
suukaudne lahus
Süsteravim
Stabiilsust ravimpreparaadid Stabiilsust mõjutavad tegurid stabiilsust mõjutavad faktorid Sobimatus Viited pdf
   keemiline struktuur  

suukaudne lahus
Viited   suukaudne lahus   Viited : Hydralazine hydrochloride  
tüüp avaldamine
2422 ajaleht Allen LV, Jr, Erickson MA,
Stability of alprazolam, chloroquine phosphate, cisapride, enalapril maleate, and hydralazine hydrochloride in extemporaneously compounded oral liquids
Am J Health-Syst Pharm 1998 ; 55: 1915-1920.
2836 ajaleht Okoka CC, Modwick T, Naira G, Khuspo S, Grady LT.
Stability of Hydralazine Hydrochloride in Both Flavored and Nonflavored Extemporaneous Preparations
Int J Pharm Compound 2003 ; 7, 4: 313-319.
3168 ajaleht Alexander KS, Pudipeddi M, Parker GA.
Stability of hydralazine hydrochloride syrup compounded from tablets.
Am J Hosp Pharm 1993 ; 50: 683-686.
4408 ajaleht Polonini H, Loures da Silva S, Neves Cunha C, de Oliveira Ferreira A, Anagnostou K, Dijkers E.
Stability of Azathioprine, Clonidine Hydrochloride, Clopidogrel Bisulfate, Ethambutol Hydrochloride, Griseofulvin, Hydralazine Hydrochloride, Nitrofurantoin, and Thioguanine Oral Suspensions Compounded with SyrSpend SF PH4.
Int J Pharm Compound 2020 ;24,3:252-262

  Mentions Légales